Skip to main content
Erschienen in: Surgical Endoscopy 3/2017

15.07.2016

Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m2

verfasst von: Ke Gong, Kai Li, Nengwei Zhang, Bin Zhu, Dexiao Du, Dongdong Zhang, Zhen Zhang, Jirun Peng

Erschienen in: Surgical Endoscopy | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the Roux-en-Y gastric bypass (GBP) procedure for patients suffering from type 2 diabetes mellitus (T2DM) with body mass index (BMI) <28 kg/m2.

Methods

Thirty-one patients suffering from T2DM were selected to undergo laparoscopic Roux-en-Y gastric bypass surgery and were enrolled at Beijing Shijitan Hospital between November 2012 and December 2014. The fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), C-peptide, fasting insulin (FINS) and glucagon-like peptide-1 (GLP-1) of all patients were measured before and at 1, 3, 6 months after surgery. The results were compared and analyzed.

Results

Thirty-one patients suffering from T2DM successfully underwent GBP surgery (a mean age of 46 years), 14 were male and 17 were female. Among them, 7 patients had hypertriglyceridemia (HTG). The patients were followed up for 6 months. No major complications were found. The average BMI was 26.5 ± 1.4 kg/m2 before surgery. The average levels of FPG, HbA1c, C-peptide, FINS of all patients were statistically decreased after surgery, respectively, compared to those before surgery (P < 0.05). However, the mean GLP-1 of all patients was statistically increased after surgery compared to that before surgery (P < 0.05). At 6 months after surgery, 22 patients (71 %) achieved complete remission of T2DM with HbA1c < 6.5 %, 7 patients (23 %) gained partial remission of T2DM with 6.5 % ≤ HbA1c < 7.0 % and 2 patients (6 %) experienced no remission of T2DM. The mean serum triglyceride of 31 patients was statistically decreased after surgery compared to that before surgery (P < 0.05).

Conclusions

This research shows that the GBP procedure is safe and effective for T2DM patients with BMI <28 kg/m2, and the condition of patients with HTG was greatly improved. However, further studies with larger samples and long-term follow-up are needed.
Literatur
1.
Zurück zum Zitat Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed
2.
Zurück zum Zitat IDF Diabetes Atlas Group (2015) Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res Clin Pract 109:461–465CrossRefPubMed IDF Diabetes Atlas Group (2015) Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res Clin Pract 109:461–465CrossRefPubMed
3.
Zurück zum Zitat Douglas IJ, Bhaskaran K, Batterham RL, Smeeth L (2015) Bariatric surgery in the United Kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med 22(12):e1001925CrossRef Douglas IJ, Bhaskaran K, Batterham RL, Smeeth L (2015) Bariatric surgery in the United Kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med 22(12):e1001925CrossRef
4.
Zurück zum Zitat Ribaric G, Buchwald JN, McGlennon TW (2014) Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 24:437–455CrossRefPubMed Ribaric G, Buchwald JN, McGlennon TW (2014) Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 24:437–455CrossRefPubMed
6.
Zurück zum Zitat Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009) The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88CrossRefPubMedPubMedCentral Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009) The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ (2010) Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal diabetes. Ann Surg 252:559–567PubMed Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ (2010) Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal diabetes. Ann Surg 252:559–567PubMed
8.
Zurück zum Zitat Maiz C, Alvarado J, Quezada N, Salinas J, Funke R, Boza C (2015) Bariatric surgery in 1119 patients with preoperative body mass index <35 (kg/m(2)): results at 1 year. Surg Obes Relat Dis 11:1127–1132CrossRefPubMed Maiz C, Alvarado J, Quezada N, Salinas J, Funke R, Boza C (2015) Bariatric surgery in 1119 patients with preoperative body mass index <35 (kg/m(2)): results at 1 year. Surg Obes Relat Dis 11:1127–1132CrossRefPubMed
9.
Zurück zum Zitat Basevi V, Di Mario S, Morciano C, Nonino F, Magrini N (2011) Comment on: American diabetes association. Standards of medical care in diabetes—2011. Diabetes Care 34(Suppl. 1):S11–S61 Basevi V, Di Mario S, Morciano C, Nonino F, Magrini N (2011) Comment on: American diabetes association. Standards of medical care in diabetes—2011. Diabetes Care 34(Suppl. 1):S11–S61
10.
Zurück zum Zitat Chinese Society for Metabolic & Bariatric Surgery (CSMBS) (2014) Surgery guideline for Chinese obesity and type 2 diabetes. Chin J Pract Surg 34:1005–1010 Chinese Society for Metabolic & Bariatric Surgery (CSMBS) (2014) Surgery guideline for Chinese obesity and type 2 diabetes. Chin J Pract Surg 34:1005–1010
11.
Zurück zum Zitat Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–352CrossRefPubMedPubMedCentral Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–352CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A (1998) Biliopancreatic diversion. World J Surg 22:936–946CrossRefPubMed Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A (1998) Biliopancreatic diversion. World J Surg 22:936–946CrossRefPubMed
13.
Zurück zum Zitat Omotosho P, Mor A, Shantavasinkul PC, Corsino L, Torquati A (2016) Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes. Surg Endosc 30(7):2857–2864CrossRefPubMed Omotosho P, Mor A, Shantavasinkul PC, Corsino L, Torquati A (2016) Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes. Surg Endosc 30(7):2857–2864CrossRefPubMed
14.
Zurück zum Zitat Dicker D, Yahalom R, Comaneshter DS, Vinker S (2015) Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg (Epub ahead of print) Dicker D, Yahalom R, Comaneshter DS, Vinker S (2015) Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg (Epub ahead of print)
15.
Zurück zum Zitat Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC (2008) Effects of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg 12:945–952CrossRefPubMed Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC (2008) Effects of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg 12:945–952CrossRefPubMed
16.
Zurück zum Zitat Lakdawala M, Bhasker A, Asian Consensus Meeting on Metabolic Surgery (ACMOMS) (2010) Report: Asian consensus meeting on metabolic surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type 2 diabetes mellitus in the Asian population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg 20:929–936CrossRefPubMed Lakdawala M, Bhasker A, Asian Consensus Meeting on Metabolic Surgery (ACMOMS) (2010) Report: Asian consensus meeting on metabolic surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type 2 diabetes mellitus in the Asian population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg 20:929–936CrossRefPubMed
17.
Zurück zum Zitat Yang J, Wang C, Cao G, Yang W, Yu S, Zhai H, Pan Y (2015) Long-term effects of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28–35 kg/m2. BMC Surg 15:88CrossRefPubMedPubMedCentral Yang J, Wang C, Cao G, Yang W, Yu S, Zhai H, Pan Y (2015) Long-term effects of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28–35 kg/m2. BMC Surg 15:88CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lakdawala M, Shaikh S, Bandukwala S, Remedios C, Shah M, Bhasker AG (2013) Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30–35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis 9:370–378CrossRefPubMed Lakdawala M, Shaikh S, Bandukwala S, Remedios C, Shah M, Bhasker AG (2013) Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30–35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis 9:370–378CrossRefPubMed
19.
Zurück zum Zitat Yin J, Xu L, Mao Z, Zhou X, Zhu Z, Chen X, Sun J, Mu L, Peng C, Qian H, Yang Y (2014) Laparoscopic Roux-en-Y gastric bypass for type 2 diabetes mellitus in nonobese Chinese patients. Surg Laparosc Endosc Percutaneous Tech 24:e200–e206 Yin J, Xu L, Mao Z, Zhou X, Zhu Z, Chen X, Sun J, Mu L, Peng C, Qian H, Yang Y (2014) Laparoscopic Roux-en-Y gastric bypass for type 2 diabetes mellitus in nonobese Chinese patients. Surg Laparosc Endosc Percutaneous Tech 24:e200–e206
20.
Zurück zum Zitat Park JY, Kim YJ (2015) Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass. Obes Surg (Epub ahead of print) Park JY, Kim YJ (2015) Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass. Obes Surg (Epub ahead of print)
21.
22.
Zurück zum Zitat Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236–242CrossRefPubMedPubMedCentral Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236–242CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL (2005) Effects of Roux-en-Y-gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90:359–365CrossRefPubMed Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL (2005) Effects of Roux-en-Y-gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90:359–365CrossRefPubMed
24.
Zurück zum Zitat le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108–114CrossRefPubMedPubMedCentral le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108–114CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Gallwitz B (2016) Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 23:23–27CrossRefPubMed Gallwitz B (2016) Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 23:23–27CrossRefPubMed
26.
Zurück zum Zitat Zethelius B, Hales CN, Lithell HO, Berne C (2004) Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 27:1433–1438CrossRefPubMed Zethelius B, Hales CN, Lithell HO, Berne C (2004) Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 27:1433–1438CrossRefPubMed
27.
Zurück zum Zitat Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE (2012) Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 35:1420–1428CrossRefPubMedPubMedCentral Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE (2012) Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 35:1420–1428CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Arterburn D, Schauer DP, Wise RE, Gersin KS, Fischer DR, Selwyn CA Jr, Erisman A, Tsevat J (2009) Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg 19:184–189CrossRefPubMed Arterburn D, Schauer DP, Wise RE, Gersin KS, Fischer DR, Selwyn CA Jr, Erisman A, Tsevat J (2009) Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg 19:184–189CrossRefPubMed
29.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142:621–632CrossRefPubMed Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142:621–632CrossRefPubMed
30.
Zurück zum Zitat Birkmeyer NJ, Dimick JB, Share D, Hawasli A, English WJ, Genaw J, Finks JF, Carlin AM, Birkmeyer JD, Michigan Bariatric Surgery Collaborative (2010) Hospital complication rates with bariatric surgery in Michigan. JAMA 304:435–442CrossRefPubMed Birkmeyer NJ, Dimick JB, Share D, Hawasli A, English WJ, Genaw J, Finks JF, Carlin AM, Birkmeyer JD, Michigan Bariatric Surgery Collaborative (2010) Hospital complication rates with bariatric surgery in Michigan. JAMA 304:435–442CrossRefPubMed
31.
Zurück zum Zitat Gong K, Gagner M, Pomp A, Almahmeed T, Bardaro SJ (2008) Micronutrients deficiencies following laparoscopic gastric bypass: recommendations. Obes Surg 18:1062–1066CrossRefPubMed Gong K, Gagner M, Pomp A, Almahmeed T, Bardaro SJ (2008) Micronutrients deficiencies following laparoscopic gastric bypass: recommendations. Obes Surg 18:1062–1066CrossRefPubMed
32.
Zurück zum Zitat John S, Hoegerl C (2009) Nutritional deficiencies after gastric bypass surgery. J Am Osteopath Assoc 109:601–604PubMed John S, Hoegerl C (2009) Nutritional deficiencies after gastric bypass surgery. J Am Osteopath Assoc 109:601–604PubMed
Metadaten
Titel
Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m2
verfasst von
Ke Gong
Kai Li
Nengwei Zhang
Bin Zhu
Dexiao Du
Dongdong Zhang
Zhen Zhang
Jirun Peng
Publikationsdatum
15.07.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 3/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5087-3

Weitere Artikel der Ausgabe 3/2017

Surgical Endoscopy 3/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.